Assignee
HONGENE BIOTECH CORP
US·15 granted patents·5 pending applications·14 citations·filing 2021–2025
Top patents by PatentIndex Score
20 records- 0194US11725073B2Compositions and methods for liquid phase oligonucleotide synthesisHONGENE BIOTECH CORP·Filed 2021·Granted Aug 15, 2023·3 cites·31 claims
- 0293US11649260B2Functionalized N-acetylgalactosamine nucleosidesHONGENE BIOTECH CORP·Filed 2022·Granted May 16, 2023·3 cites·23 claims
- 0392US11851454B2Compositions and methods for liquid phase oligonucleotide synthesisHONGENE BIOTECH CORP·Filed 2022·Granted Dec 26, 2023·2 cites·28 claims
- 0492US11814450B2Polymeric solid support for oligonucleotide synthesisHONGENE BIOTECH CORP·Filed 2022·Granted Nov 14, 2023·2 cites·30 claims
- 0592US11692001B2Functionalized n-acetylgalactosamine analogsHONGENE BIOTECH CORP·Filed 2022·Granted Jul 4, 2023·3 cites·31 claims
- 0690US11884691B2Functionalized n-acetylgalactosamine analogsHONGENE BIOTECH CORP·Filed 2023·Granted Jan 30, 2024·1 cites·27 claims
- 0781US12065516B2Polymeric solid support for oligonucleotide synthesisHONGENE BIOTECH CORP·Filed 2023·Granted Aug 20, 2024·0 cites·20 claims
- 0880US12065460B2Compositions and methods for liquid phase oligonucleotide synthesisHONGENE BIOTECH CORP·Filed 2023·Granted Aug 20, 2024·0 cites·20 claims
- 0979US2025034192A1Compositions and methods for liquid phase oligonucleotide synthesisHONGENE BIOTECH CORP·Filed 2024·Application pending·0 cites
- 1077US12180140B2Compounds and methods for liquid phase oligonucleotide synthesisHONGENE BIOTECH CORP·Filed 2023·Granted Dec 31, 2024·0 cites·26 claims
- 1177US12134630B2Compositions and methods for liquid phase oligonucleotide synthesisHONGENE BIOTECH CORP·Filed 2023·Granted Nov 5, 2024·0 cites·38 claims
- 1277US2025027091A1Lipid-pegylated compounds, preparations and uses thereofHONGENE BIOTECH CORP·Filed 2024·Application pending·0 cites
- 1376US2024287120A1Functionalized n-acetylgalactosamine analogsHONGENE BIOTECH CORP·Filed 2024·Application pending·0 cites
- 1475US12098371B2Lipid-pegylated compounds, preparations and uses thereofHONGENE BIOTECH CORP·Filed 2023·Granted Sep 24, 2024·0 cites·27 claims
- 1574US2025320177A1Compounds and methods for liquid phase oligonucleotide synthesisHONGENE BIOTECH CORP·Filed 2024·Application pending·0 cites
- 1672US11993626B2Functionalized N-acetylgalactosamine analogsHONGENE BIOTECH CORP·Filed 2022·Granted May 28, 2024·0 cites·31 claims
- 1766US12092606B2Compositions and kits comprising interpenetrating polymer network for capillary electrophoresisHONGENE BIOTECH CORP·Filed 2021·Granted Sep 17, 2024·0 cites·27 claims
- 1865US11897914B2Synthesis of 2′ protected nucleosidesHONGENE BIOTECH CORP·Filed 2022·Granted Feb 13, 2024·0 cites·23 claims
- 1962US12116382B2Functionalized N-acetylgalactosamine analogsHONGENE BIOTECH CORP·Filed 2023·Granted Oct 15, 2024·0 cites·49 claims
- 2052US2026001904A1Compounds and methods for liquid phase oligonucleotide synthesisHONGENE BIOTECH CORP·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when HONGENE BIOTECH CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →